Michael A Purdy

Title: Michael A. Purdy: Innovator in Hepatitis E Vaccine Development

Introduction

Michael A. Purdy is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of vaccine development, particularly in relation to the Hepatitis E virus. With a total of 3 patents to his name, Purdy's work has the potential to impact public health positively.

Latest Patents

Purdy's latest patents include a Hepatitis E virus vaccine and method, which discloses an antigen and antibody vaccine composition effective in preventing Hepatitis E virus (HEV) infection. The antigen composition comprises peptides corresponding to the carboxyl terminal end regions of the second and third open reading frames of the HEV genome. This composition is effective in preventing HEV infection after vaccination. Additionally, the antibody composition contains an antibody that effectively blocks HEV infection of human primary hepatocytes in culture. Another significant patent involves Hepatitis E virus ORF Z peptides, which also focuses on antigen compositions related to HEV infection.

Career Highlights

Throughout his career, Michael A. Purdy has worked with reputable organizations, including Genelabs Technologies, Inc. and the United States of America as represented by the Department of Health. His work in these institutions has allowed him to contribute to important advancements in medical research and vaccine development.

Collaborations

Purdy has collaborated with notable professionals in his field, including Gregory R. Reyes and Daniel W. Bradley. These collaborations have likely enriched his research and contributed to the success of his innovations.

Conclusion

Michael A. Purdy's contributions to the development of vaccines against Hepatitis E highlight his role as an important inventor in the medical field. His innovative work continues to pave the way for advancements in public health.